Open Access

Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma

  • Authors:
    • Yang Zhang
    • Junwei Zhu
  • View Affiliations

  • Published online on: December 4, 2018     https://doi.org/10.3892/or.2018.6903
  • Pages: 908-916
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glioma originates from the glial cells of the spine or brain, and promoter methylation of O6‑methylguanine‑DNA methyltransferase (MGMT) can promote the chemosensitivity of glioma. The present study aimed to reveal the key genes implicated in MGMT promoter methylation in patients with glioma. RNA‑sequencing data and methylation data for glioma were extracted from The Cancer Genome Atlas database. Following expression characteristic analysis and differential expression analysis using unsupervised hierarchical clustering and a rank sum test, the feature genes were identified between high and low methylation groups. Furthermore, multivariate survival analysis for the feature genes was performed using the survival package in R. Additionally, the independent glioma RNA expression datasets GSE7696 and GSE42669 were used to validate the prognostic efficiency of the gene combination. The results indicated that the prognosis of the low methylation group was significantly worse than that of the high methylation group. The ten genes corresponding to the cut‑off value of 0.56 (Rho GTPase‑activating protein 21, CECR2, histone acetyl‑lysine reader, endosulfine α, G‑patch domain‑containing 8, KIAA1109, MGMT, protocadherin β 13, selenoprotein M, sperm‑associated antigen 9 and WD repeat domain 6) were able to significantly predict prognosis and were differentially expressed between the two groups. Multivariate survival analysis suggested that the ten genes were effective for sample classification and prognostic prediction. Furthermore, the validation datasets confirmed the correlation of the ten genes with prognosis. In conclusion, these 10 genes may be mediated by MGMT promoter methylation in glioma. In addition, the ten‑gene combination may be associated with the prognosis of patients with glioma.
View Figures
View References

Related Articles

Journal Cover

February-2019
Volume 41 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y and Zhang Y: Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma. Oncol Rep 41: 908-916, 2019
APA
Zhang, Y., & Zhang, Y. (2019). Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma. Oncology Reports, 41, 908-916. https://doi.org/10.3892/or.2018.6903
MLA
Zhang, Y., Zhu, J."Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma". Oncology Reports 41.2 (2019): 908-916.
Chicago
Zhang, Y., Zhu, J."Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma". Oncology Reports 41, no. 2 (2019): 908-916. https://doi.org/10.3892/or.2018.6903